Changes

Jump to: navigation, search

B-cell acute lymphoblastic leukemia - historical

416 bytes removed, 15:50, 2 January 2019
m
no edit summary
|[http://www.bloodjournal.org/content/64/1/267.long Gottlieb et al. 1984 (CALGB 7612)]
|style="background-color:#1a9851"|Randomized (C)
|[[B-cell_acute_lymphoblastic_leukemia#Daunorubicin.2C_L-Asparaginase.2C_Vincristine.2C_PrednisoneDOLP|Daunorubicin, L-Asparaginase, Vincristine, PrednisoneDOLP]]
|style="background-color:#d73027"|Inferior CR rate
|-
|[https://www.ncbi.nlm.nih.gov/pubmed/2665546 van der Does-van den Berg et al. 1989 (DCLSG ALL V)]
|style="background-color:#1a9851"|Phase III (C)
|[[B-cell_acute_lymphoblastic_leukemia#Daunorubicin.2C_L-Asparaginase.2C_Vincristine.2C_PrednisoneDOLP|Daunorubicin, L-Asparaginase, Vincristine, PrednisoneDOLP]]
|style="background-color:#ffffbf"|Seems not superior
|-
|[https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1365-2141.1991.tb04415.x Eden et al. 1991 (MRC UKALL VIII)]
|style="background-color:#1a9851"|Phase III (C)
|[[B-cell_acute_lymphoblastic_leukemia#Daunorubicin.2C_L-Asparaginase.2C_Vincristine.2C_PrednisoneDOLP|Daunorubicin, L-Asparaginase, Vincristine, PrednisoneDOLP]]
|style="background-color:#ffffbf"|Seems not superior
|-
|[http://ascopubs.org/doi/abs/10.1200/JCO.1993.11.3.527 Tubergen et al. 1993 (CCG-105)]
|style="background-color:#1a9851"|Phase III (C)
|[[B-cell_acute_lymphoblastic_leukemia#Daunorubicin.2C_L-Asparaginase.2C_Vincristine.2C_PrednisoneDOLP|Daunorubicin, L-Asparaginase, Vincristine, PrednisoneDOLP]]
|style="background-color:#d3d3d3"|Not reported
|-
LookupUsers, editors, emailconfirmed
24,604
edits

Navigation menu